introduction hidradenitis suppurativa chronic inflammatory skin condition affect terminal hair follicle mainly intertriginous skin area axillary groin perianal perineal inframammary region characterized presence recurrent painful nodule area patient often negatively perceived stigmatized leading impaired quality life qol poor body image higher incidence psychiatric disorder anxiety depression cutaneous body image cbi may defined individual mental perception appearance integumentary system i.e. skin hair nail cutaneous body image scale cbis important dermatologic construct—both wide range cosmetically disfiguring skin disorder cbi dissatisfaction profound impact quality life qol patient situation cbi distorted body dysmorphic disorder seven-item scale patient dissatisfaction cbi often primary consideration deciding whether commence treatment skin disorder cause disfigurement mainly intertriginous skin area axillary groin perianal perineal inframammary region expected impaired cbi patient study aim evaluate cbi patient whether disease severity topography lesion age onset disease duration obesity general health anxiety depression linked cbi impairment material method prospective non-interventional observational cross-sectional study conducted tertiary referral hospital greece consecutive patient hidradenitis suppurativa age willing participate study obtaining informed consent subject age parental consent patient age recruited dermatology department first visit july january inclusion criterion age willingness participate together parental consent patient age iii clinical diagnosis made experienced dermatologist capability completing qol questionnaire administered ethic committee approval obtained study informed written consent provided participant procedure followed ethical standard responsible institutional ethic committee helsinki declaration revised participant examined dermatologist provided information clinical characteristic affected body area past medical history comorbidities treatment disease severity assessed clinician following three measure hurley staging hidradenitis suppurativa-physician global assessment hs-pga disease modified sartorius score patient also asked rate disease severity using scale indicated clear disease represented severe disease hs-related pain intensity scale indicated pain pain bad could hs-related pruritus severity using scale indicated pruritus represented severe pruritus lesion participant completed seven paper-based questionnaire table cbis multidimensional body-self relation questionnaire-appearance scale mbsrq-as contains five appearance-related item appearance evaluation appearance orientation body area satisfaction scale bass overweight preoccupation owp self classified weight scw item two skin-specific quality life qol instrument dermatology life quality index dlqi skindex-16 general general health-related quality life hrqol eq-5d-5l visual analog scale eq-vas patient health questionnaire-9 phq-9 assessing depression gad-7 generalized anxiety disorder screening anxiety see supplementary file table brief description main quality life questionnaire qol used study full size table statistical analysis baseline patient demographic disease characteristic comorbidities summarized descriptively mean continuous variable count percentage categorical variable non-parametric mann–whitney kruskal–wallis test used compare patient- physician-based outcome score analysis relationship continuous variable accomplished calculating spearman correlation coefficient weak correlation 0.2 moderate correlation 0.4 0.6 strong correlation 0.6 significance threshold adjusted bonferroni correction statistical test association cbis continuous variable also studied using logistic regression analysis statistical test performed using spss window v25 threshold statistical significance set 0.05 test ethical approval approval obtained ethical review board university hospital heraklion heraklion crete method used study comply principle declaration helsinki consent participate participant gave explicit written informed consent participation study participant age year old also legal guardian consented participate study result total consecutive patient active disease least one flare last month recruited outpatient clinic dermatology department tertiary referral hospital greece july january 21/70 female 49/70 male mean age patient 34.33 standard deviation 11.64 year mean age onset 22.33 7.60 year mean duration disease 12.11 9.53 year hurley stage 13/70 18.6 hurley stage 41/70 58.6 hurley stage iii 16/70 22.9 patient baseline demographic disease characteristic comorbidities shown table table patient demographic clinical characteristic quality life questionnaire study patient hidradenitis suppurativa correlation cutaneous body image scale cbis full size table mean value cbis patient 5.97 1.58 table 36/70 51.4 mild dissatisfaction cbi 33/70 47.1 moderate dissatisfaction 1/70 1.4 severe dissatisfaction cbi table mean cbis dlqi skindex-16 total eq-5d-5l phq9 gad7 5.59 1.58 11.70 8.88 52.90 27.75 0.75 0.21 62.48 21.12 7.64 5.56 7.87 5.23 respectively fixed effect demographic clinical factor cbis mbbs anxiety depression eq5d5l eqvas dlqi overall skindex-16 score within domain score investigated using univariate multivariate analysis multiple linear regression showed cbi dissatisfaction correlated mbsrq 0.01 bass 0.01 bmi predictor 0.01 bass 0.02 scw 0.01 skindex-16 total 0.02 depression 0.03 pain severity also predictor depression 0.01 furthermore patient hurley stage lower eqvas 0.01 others indicating probably lower overall assessment health male patient scored higher skindex-16 female patient affected genital area considered skin disease severe scored higher patient disease severity score 0.01 smoker younger age onset 0.02 scored higher pain 0.01 quality life measured skindex-16-total 0.01 eqvas 0.01 depression assessed phq-9 0.01 discussion study assessed cbis patient also evaluated relationship cbis demographic clinical parameter health-related quality life measure among patient revealing important information may inform approach group patient study mean cbi value 4.11 2.72 previous study dermatology patient conducted canada reported mean cbis score possible variation 4.44 1.56 sample 28.3 acne 21.3 psoriasis 40.1 onychomycosis/athletes foot 10.3 atopic dermatitis/alopecia/other mean cbis much decreased 0.004 4.96 1.73 score person belonging community-based nonclinical group consistent greater body image dissatisfaction dermatology group likewise study conducted japan cbis value dermatology patient 3.18 1.69 much lower among healthy individual 4.11 1.80 probably lower mean score japanese individual canadian suggest japanese group greater cbi concern previous study showed correlation cbi body dissatisfaction subscale eating disorder inventory global appearance-related self-esteem negative experience skin disease embarrassment bullying age study cbi dissatisfaction correlated bass patient genital area affected scored higher patient severity disease bmi predictor skindex-total bass scw depression previous study shown patient frequently reduced quality life depression impaired body image compared healthy control psychological condition called alexithymia characterized lack emotional expression description awareness evidence linking alexithymia broadening range psychological disease linked patient may affected phenomenon fear stigmatization exclusion patient find skin lesion extremely uncomfortable unattractive believe unclean feel embarrassed well aware unpleasant discharge nodule pustule smell heavily discharged n't look companionship instead stay alone home according schmid-ott al. stigmatization experience vary visible lesion endure greater degree stigmatization unseen lesion patient fall visible unseen discredited discreditable category event may eventually affect patient self-perceptions resulting internalized skin bias isb recently questionnaire evaluating internalized skin bias isb validated patient stigmatization may result impaired body image perception patient internalize society judgment could severe impact ability access medical care order improve quality health care crucial address internalized stigma addition disease activity psychodermatological approach enhances qol disease flare-up long-term management condition limitation study considered first patient recruited single center tertiary referral hospital may differ practice therefore generalizability study result may limited second study enrolled limited number patient control group participant examined single time point future study collect longitudinal data multiple point time approach may yield information cbi change remains stable time depending treatment response conclusion recommend use cbis across various setting including clinical care clinical research patient regular evaluation cbi could beneficial validates patient concern cbi clinically relevant medical practitioner may wish document whether significant discrepancy exists patient subjective evaluation cosmetic problem objective dermatologic evaluation cosmetic effect skin disorder could indication body image pathology underlying psychiatric comorbidities patient dissatisfaction cbi often primary consideration deciding whether commence treatment various skin condition assessment cbi dermatology patient best performed using biopsychosocial model involves assessment concern appearance skin hair nail assessment comorbid body.image pathology assessment psychiatric comorbidities future prospective study treatment large cohort patient needed provide solid result conclusion finding might practical application believe employing use cbis clinical setting assist dermatologist understand patient expectation need upcoming research contrasting cbis clinical measurement follow-up visit might useful patient